{"url_path":"/sec/dgx/8-k/2026-03-12/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-12","source_url":"https://www.sec.gov/Archives/edgar/data/1022079/0000947871-26-000244-index.html","accession_number":"0000947871-26-000244","cik":"0001022079","ticker":"DGX","issuer_name":"QUEST DIAGNOSTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022079/0000947871-26-000244-index.html","primary_entity_key":"0001022079","primary_entity_name":"QUEST DIAGNOSTICS INC"},"word_count":160,"has_tables":true,"body_markdown":"**Item 5.02. Departure of Directors or Certain Officers; Election\nof Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\n(d) On March 9, 2026, the Board of Directors\n(the “Board”) of Quest Diagnostics Incorporated (the “Company”), after considering the recommendation of the Board's\nGovernance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director. The Board\nappointed Mr. Wentworth to serve on the Board’s Compensation and Leadership Development Committee and the Board’s Quality\nand Compliance Committee.\n\n \n\nThe Board determined that Mr. Wentworth is an\nindependent director pursuant to the New York Stock Exchange listing standards and the Company’s independence guidelines, as set\nforth in its corporate governance guidelines.\n\n \n\nMr. Wentworth will receive compensation as a\nnon-employee director in accordance with the Company’s non-employee director compensation practices. As part of that compensation,\nMr. Wentworth received a prorated one-time grant of restricted share units valued at approximately $43,000 upon becoming a member of the\nCompany’s Board."}